← All agents | ← Research tracker
Tdcs-Active
PubChem entry
Evidence Summary
Evidence Level: Preliminary
Mechanism: Enrollment: Actual, Neurological / Autonomic, Sponsor Type: Other, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet)
Clinical Trials
2 trial(s) registered
NCT05965752: RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms NA COMPLETED
NCT05965739: RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms NA COMPLETED
Key Studies / References